arrow
返回

Soft Tissue Sarcoma, Version 2.2018

delete2018-05-11
delete464
delete
OA
AI
M
Margaret von Mehren *
R
R. Lor Randall
R
Robert S. Benjamin
S
Sarah G Boles
M
Marilyn M. Bui
K
Kristen N. Ganjoo
S
Suzanne George
R
Ricardo J. Gonzalez
M
Martin J. Heslin
J
John M. Kane
V
Vicki L. Keedy
K
Kim, Edward
H
Henry Koon
J
Joel L. Mayerson
M
McCarter, Martin
S
Sean V. McGarry
C
Christian Meyer
Z
Zachary S. Morris
R
Richard J. O’Donnell
A
Alberto S. Pappo
I
I. Benjamin Paz
I
Ivy A. Petersen
J
John D. Pfeifer
R
Richard F. Riedel
B
Bernice Ruo
S
Scott M. Schuetze
W
William D. Tap
J
Jeffrey D. Wayne
M
Mary Anne Bergman
J
Jillian L. Scavone
DOI:10.6004/jnccn.2018.0025delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
Keyword:
POSITRON-EMISSION-TOMOGRAPHY
ISOLATED LIMB INFUSION
MODULATED RADIATION-THERAPY
NECROSIS-FACTOR-ALPHA
LONG-TERM OUTCOMES
HIGH-GRADE
NEOADJUVANT CHEMOTHERAPY
PROGNOSTIC-FACTORS
LOCAL RECURRENCE
TRUNK-WALL
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

J
Journal of the National Comprehensive Cancer Network
IF:
16.4
论文数:
2.8K
被引数:
1.5W

机构

U
utmd anderson cancer center
学者数:
3.0W
论文数: 2.4W
被引数: 27
H
h lee moffitt cancer center & research institute
学者数:
9.2K
论文数: 6.7K
被引数: 11
J
james cancer hospital & solove research institute
学者数:
4.6K
论文数: 2.7K
被引数: 8
U
University of Alabama Birmingham
学者数:
2.1W
论文数: 1.8W
被引数: 29
S
Stanford Cancer Institute
学者数:
1.6K
论文数: 1.2K
被引数: 2.3K
H
Huntsman Cancer Institute
学者数:
2.1K
论文数: 1.6K
被引数: 6.1K
U
University of Utah
学者数:
3.0W
论文数: 2.2W
被引数: 4.6W
H
Harvard University
学者数:
26.5W
论文数: 22.0W
被引数: 28.7W
Seattle Cancer Care Alliance 封面图
Seattle Cancer Care Alliance
学者数:
750
论文数: 635
被引数: 2.2K
U
University System of Ohio
学者数:
15.5W
论文数: 13.0W
被引数: 200
University of Colorado System 封面图
University of Colorado System
学者数:
6.3W
论文数: 5.5W
被引数: 1.8K
University of Alabama System 封面图
University of Alabama System
学者数:
4.2W
论文数: 3.8W
被引数: 68
D
Dana-Farber Cancer Institute
学者数:
1.5W
论文数: 9.6K
被引数: 3.8W
V
vanderbilt university
学者数:
5.1W
论文数: 4.1W
被引数: 59
C
Case Western Reserve University
学者数:
2.1W
论文数: 1.6W
被引数: 3.4W
J
Johns Hopkins University
学者数:
10.2W
论文数: 8.8W
被引数: 13.0W
U
university of texas system
学者数:
18.5W
论文数: 15.6W
被引数: 210
J
Johns Hopkins Medicine
学者数:
1.8W
论文数: 1.3W
被引数: 5.0W
C
cleveland clinic foundation
学者数:
3.7W
论文数: 3.0W
被引数: 29
U
university of colorado boulder
学者数:
2.0W
论文数: 1.5W
被引数: 33
O
Ohio State University
学者数:
4.1W
论文数: 3.2W
被引数: 80
U
Utah System of Higher Education
学者数:
4.6W
论文数: 4.0W
被引数: 161
F
Fox Chase Cancer Center
学者数:
4.9K
论文数: 4.1K
被引数: 6.7K
学者 查看更多机构
引用论文

引用论文

暂无论文信息